AMGEN TO PRESENT NEW, POSITIVE CLINICAL AND REAL-WORLD DATA ACROSS INFLAMMATION PORTFOLIO AT EADV 2022

Go back to AMGEN TO PRESENT NEW, POSITIVE CLINICAL AND REAL-WORLD DATA ACROSS INFLAMMATION PORTFOLIO AT EADV 2022
Amgen Inc (NASDAQ: AMGN) Delayed: 379.78 +3.43 (0.91%)
Previous Close $376.35    52 Week High $176.85 
Open $379.15    52 Week Low $133.64 
Day High $382.49    P/E 57.20 
Day Low $376.08    EPS $6.64 
Volume 3,234,871